FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3107576517> ?p ?o ?g. }

• W3107576517 endingPage "994" @default.
• W3107576517 startingPage "982" @default.
• W3107576517 abstract "The investigation of underlying mechanism and the exploitation of novel therapies for metastatic prostate cancer (PCa) are still urgently needed. miR-199b-5p has been suggested to function as tumour suppressor in various human cancers. However, the clinical significance and role of miR-199b-5p in PCa remain unclear.The current study sought to investigate the expression status of miR-199b-5p in PCa and the involved molecular mechanisms in PCa metastasis by using bioinformatics analyses, loss-and gain-of-functions and rescue experiments in vitro and in vivo.We demonstrated that miR-199b-5p was significantly downregulated in metastatic PCa tissues and cells when compared with the normal prostate tissue, the localised disease, the weakly metastatic and androgen-dependent PCa cell and the normal prostate epithelial cell. We also found that miR-199b-5p drastically suppressed PCa cell proliferation, migration and invasion in vitro and inhibited xenografts tumour growth and metastasis in vivo. Mechanistically, our results showed that miR-199b-5p could inhibit discoidin domain receptor tyrosine kinase 1 (DDR1) expression by directly targeting its 3'-UTR, thereby hindering epithelial-mesenchymal transition (EMT)-associated traits, which were induced by DDR1 activating ERK signalling pathway. Moreover, PCa patients with low miR-199b-5p expression level had a remarkably shorter overall survival than those with high miR-199b-5p level, indicating an association of miR-199b-5p loss with poor prognosis in patients with PCa. Furthermore, DDR1 was upregulated in PCa, and significantly correlated with high Gleason score, advanced pathological stage, tumour metastasis and shorter overall survival.Our study, for the first time, provide evidence of a tumour-suppressive function of miR-199b-5p in the invasion and metastasis of PCa, supporting the translational exploitation of miR-199b-5p-based therapeutic approaches for PCa metastases. Also, the miR-199b-5p-DDR1-ERK signalling axis identified in this study represents a novel mechanism of regulating EMT in PCa metastases." @default.
• W3107576517 created "2020-12-07" @default.
• W3107576517 creator A5002786739 @default.
• W3107576517 creator A5003105136 @default.
• W3107576517 creator A5023591621 @default.
• W3107576517 creator A5043140904 @default.
• W3107576517 creator A5046180679 @default.
• W3107576517 creator A5050824975 @default.
• W3107576517 creator A5069651727 @default.
• W3107576517 creator A5084714941 @default.
• W3107576517 date "2020-11-26" @default.
• W3107576517 modified "2023-10-18" @default.
• W3107576517 title "miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition" @default.
• W3107576517 cites W144423133 @default.
• W3107576517 cites W1598214312 @default.
• W3107576517 cites W1922439152 @default.
• W3107576517 cites W1996464919 @default.
• W3107576517 cites W2002306600 @default.
• W3107576517 cites W2002995168 @default.
• W3107576517 cites W2003821826 @default.
• W3107576517 cites W2027315940 @default.
• W3107576517 cites W2056120940 @default.
• W3107576517 cites W2107633226 @default.
• W3107576517 cites W2141196759 @default.
• W3107576517 cites W2272984102 @default.
• W3107576517 cites W2297557868 @default.
• W3107576517 cites W2311257231 @default.
• W3107576517 cites W2541708186 @default.
• W3107576517 cites W2606292771 @default.
• W3107576517 cites W2610694163 @default.
• W3107576517 cites W2622265135 @default.
• W3107576517 cites W2745527255 @default.
• W3107576517 cites W2762586391 @default.
• W3107576517 cites W2774258350 @default.
• W3107576517 cites W2888056128 @default.
• W3107576517 cites W2889646458 @default.
• W3107576517 cites W2895979054 @default.
• W3107576517 cites W2901068426 @default.
• W3107576517 cites W2936065541 @default.
• W3107576517 cites W2984115775 @default.
• W3107576517 cites W3003197783 @default.
• W3107576517 cites W3004437380 @default.
• W3107576517 doi "https://doi.org/10.1038/s41416-020-01187-8" @default.
• W3107576517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8367950" @default.
• W3107576517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34285381" @default.
• W3107576517 hasPublicationYear "2020" @default.
• W3107576517 type Work @default.
• W3107576517 sameAs 3107576517 @default.
• W3107576517 citedByCount "22" @default.
• W3107576517 countsByYear W31075765172021 @default.
• W3107576517 countsByYear W31075765172022 @default.
• W3107576517 countsByYear W31075765172023 @default.
• W3107576517 crossrefType "journal-article" @default.
• W3107576517 hasAuthorship W3107576517A5002786739 @default.
• W3107576517 hasAuthorship W3107576517A5003105136 @default.
• W3107576517 hasAuthorship W3107576517A5023591621 @default.
• W3107576517 hasAuthorship W3107576517A5043140904 @default.
• W3107576517 hasAuthorship W3107576517A5046180679 @default.
• W3107576517 hasAuthorship W3107576517A5050824975 @default.
• W3107576517 hasAuthorship W3107576517A5069651727 @default.
• W3107576517 hasAuthorship W3107576517A5084714941 @default.
• W3107576517 hasBestOaLocation W31075765171 @default.
• W3107576517 hasConcept C101544691 @default.
• W3107576517 hasConcept C104317684 @default.
• W3107576517 hasConcept C121608353 @default.
• W3107576517 hasConcept C126322002 @default.
• W3107576517 hasConcept C127561419 @default.
• W3107576517 hasConcept C152681006 @default.
• W3107576517 hasConcept C170493617 @default.
• W3107576517 hasConcept C2776235491 @default.
• W3107576517 hasConcept C2776305115 @default.
• W3107576517 hasConcept C2779013556 @default.
• W3107576517 hasConcept C2780192828 @default.
• W3107576517 hasConcept C502942594 @default.
• W3107576517 hasConcept C54355233 @default.
• W3107576517 hasConcept C55493867 @default.
• W3107576517 hasConcept C57074206 @default.
• W3107576517 hasConcept C62112901 @default.
• W3107576517 hasConcept C62478195 @default.
• W3107576517 hasConcept C71924100 @default.
• W3107576517 hasConcept C76419328 @default.
• W3107576517 hasConcept C86803240 @default.
• W3107576517 hasConcept C95444343 @default.
• W3107576517 hasConceptScore W3107576517C101544691 @default.
• W3107576517 hasConceptScore W3107576517C104317684 @default.
• W3107576517 hasConceptScore W3107576517C121608353 @default.
• W3107576517 hasConceptScore W3107576517C126322002 @default.
• W3107576517 hasConceptScore W3107576517C127561419 @default.
• W3107576517 hasConceptScore W3107576517C152681006 @default.
• W3107576517 hasConceptScore W3107576517C170493617 @default.
• W3107576517 hasConceptScore W3107576517C2776235491 @default.
• W3107576517 hasConceptScore W3107576517C2776305115 @default.
• W3107576517 hasConceptScore W3107576517C2779013556 @default.
• W3107576517 hasConceptScore W3107576517C2780192828 @default.
• W3107576517 hasConceptScore W3107576517C502942594 @default.
• W3107576517 hasConceptScore W3107576517C54355233 @default.
• W3107576517 hasConceptScore W3107576517C55493867 @default.
• W3107576517 hasConceptScore W3107576517C57074206 @default.

• next